Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
Lucena MI, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-González JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Pérez-Alvarez R, Borraz Y, Hidalgo R; Spanish Group for the Study of Drug-Induced Liver Disease. Lucena MI, et al. Hepatology. 2009 Jun;49(6):2001-9. doi: 10.1002/hep.22895. Hepatology. 2009. PMID: 19475693
Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.
Romero-Gómez M, Gómez-González E, Madrazo A, Vera-Valencia M, Rodrigo L, Pérez-Alvarez R, Pérez-López R, Castellano-Megias VM, Nevado-Santos M, Alcón JC, Solá R, Pérez-Moreno JM, Navarro JM, Andrade RJ, Salmerón J, Fernández-López M, Aznar R, Diago M. Romero-Gómez M, et al. Hepatology. 2008 Mar;47(3):810-6. doi: 10.1002/hep.22112. Hepatology. 2008. PMID: 18098299
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis.
Calleja JL, Pascasio JM, Ruiz-Antorán B, Gea F, Bárcena R, Larrubia JR, Pérez-Álvarez R, Sousa JM, Romero-Gómez M, Solá R, de la Revilla J, Crespo J, Navarro JM, Arenas JI, Delgado M, Fernández-Rodríguez CM, Planas R, Buti M, Forns X; Spanish Group for the Study of the Use of Direct-Acting Drugs Hepatitis C with Severe Fibrosis. Calleja JL, et al. Liver Int. 2015 Jan;35(1):90-100. doi: 10.1111/liv.12656. Epub 2014 Sep 15. Liver Int. 2015. PMID: 25113158 Clinical Trial.
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.
Vidal-Castiñeira JR, López-Vázquez A, Alonso-Arias R, Moro-García MA, Martinez-Camblor P, Melón S, Prieto J, López-Rodriguez R, Sanz-Cameno P, Rodrigo L, Pérez-López R, Pérez-Álvarez R, López-Larrea C. Vidal-Castiñeira JR, et al. J Hepatol. 2012 Jun;56(6):1230-8. doi: 10.1016/j.jhep.2012.01.011. Epub 2012 Feb 7. J Hepatol. 2012. PMID: 22322230
Acute hepatitis C in Spain: a retrospective study of 131 cases.
Pérez-Álvarez R, García-Samaniego J, Solá R, Pérez-López R, Bárcena R, Planas R, Cañete N, Manzano ML, Gutiérrez ML, Morano L, Rodrigo L. Pérez-Álvarez R, et al. Rev Esp Enferm Dig. 2012 Feb;104(1):21-8. doi: 10.4321/s1130-01082012000100005. Rev Esp Enferm Dig. 2012. PMID: 22300113 English, Spanish.
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.
Vidal-Castiñeira JR, López-Vázquez A, Martínez-Borra J, Martínez-Camblor P, Prieto J, López-Rodríguez R, Sanz-Cameno P, de la Vega J, Rodrigo L, Pérez-López R, Pérez-Álvarez R, López-Larrea C. Vidal-Castiñeira JR, et al. PLoS One. 2014 Jun 13;9(6):e99426. doi: 10.1371/journal.pone.0099426. eCollection 2014. PLoS One. 2014. PMID: 24927414 Free PMC article.
Porphyria cutanea tarda with multiple nodular foci in the liver.
Pérez Álvarez R, Pérez López R, González Sotorrío N, Rodrigo Sáez L. Pérez Álvarez R, et al. Gastroenterol Hepatol. 2012 Jan;35(1):50-2. doi: 10.1016/j.gastrohep.2011.08.005. Epub 2011 Nov 23. Gastroenterol Hepatol. 2012. PMID: 22115986 No abstract available.
117 results